Primordial Genetics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Primordial Genetics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11317
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Primordial Genetics Inc (Primordial Genetics) is a biotechnology company that provides genetic and synthetic biology solutions for protein engineering and microbial improvement. The company develops improved bacterial and yeast strains for commercial protein production and protein expression. It uses function generator technology for genome-wide combination and re-assortment of coding sequences in translational fusions to generate novel genes. Primordial Genetics produces bacterial strains for creating L-methionine which is used in poultry and swine feed. The company also holds expertise in immunoglobulin expression in E.coli including monoclonal antibodies. It also assists in discovering proteins such as new therapeutics, enzymes, and trait genes for microbes and plants, among others. The company concentrates on the discovery and production of chemicals and pharmaceuticals through genetic optimizations of actinomycete bacteria and microbial sources of natural products. Primordial Genetics is headquartered in San Diego, California, the US.

Primordial Genetics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Primordial Genetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Primordial Genetics Raises USD0.4 Million in Venture Financing 9
Primordial Genetics Raises USD0.6 Million in Venture Financing 10
Primordial Genetics Raises Funds in Series A-2 Financing 11
Primordial Genetics Raises USD0.4 Million in Financing Round 12
Primordial Genetics Raises US$0.2 Million 13
Primordial Genetics Inc – Key Competitors 14
Primordial Genetics Inc – Key Employees 15
Primordial Genetics Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Oct 01, 2018: Primordial Genetics awarded National Institutes of Health “America’s Seed Fund” grant 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Primordial Genetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Primordial Genetics Raises USD0.4 Million in Venture Financing 9
Primordial Genetics Raises USD0.6 Million in Venture Financing 10
Primordial Genetics Raises Funds in Series A-2 Financing 11
Primordial Genetics Raises USD0.4 Million in Financing Round 12
Primordial Genetics Raises US$0.2 Million 13
Primordial Genetics Inc, Key Competitors 14
Primordial Genetics Inc, Key Employees 15

List of Figures
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Primordial Genetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Primordial Genetics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chiyoda Corporation:企業の戦略・SWOT・財務分析
    Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report Summary Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Shadin Avionics LP:企業の戦略・SWOT・財務分析
    Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report Summary Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Endesa SA:発電所・企業SWOT分析
    Endesa SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Celsion Corp (CLSN):医療機器:M&Aディール及び事業提携情報
    Summary Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), T …
  • Lietuvos Draudimas AB:企業の戦略的SWOT分析
    Lietuvos Draudimas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Anglo American Plc:企業の戦略・SWOT・財務情報
    Anglo American Plc - Strategy, SWOT and Corporate Finance Report Summary Anglo American Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cameron International Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Cameron International Corporation (Cameron), a subsidiary of Schlumberger Limited specializes in engineering, designing, and manufacturing flow and pressure control technologies for oil and gas industry. The company offers drilling systems, dryaccess deepwater production systems, safety syst …
  • Novaliq GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops novel ophthalmic and dermatological products, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears, a pres …
  • Doctor’s Associates Inc:企業の戦略・SWOT・財務情報
    Doctor's Associates Inc - Strategy, SWOT and Corporate Finance Report Summary Doctor's Associates Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Textron Systems Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Midland Power Cooperative:企業の戦略的SWOT分析
    Midland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Achaogen Inc (AKAO):製薬・医療:M&Aディール及び事業提携情報
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company offers plazomicin for the treatment of serious bacterial infections including urinary t …
  • PerkinElmer Inc (PKI):医療機器:M&Aディール及び事業提携情報
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company’s major products include cytogenetics reagen …
  • Biotec Pharmacon ASA (BIOTEC):企業の財務・戦略的SWOT分析
    Summary Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company provides products which are used in the areas of human medicine such as immunotherapy of cancer, general infection …
  • Utair Aviation:企業の戦略・SWOT・財務分析
    Utair Aviation - Strategy, SWOT and Corporate Finance Report Summary Utair Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Banque de Luxembourg:企業の戦略・SWOT・財務情報
    Banque de Luxembourg - Strategy, SWOT and Corporate Finance Report Summary Banque de Luxembourg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pudumjee Paper Products Limited:戦略・SWOT・企業財務分析
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Caretech Holdings Plc (CTH):企業の財務・戦略的SWOT分析
    Summary Caretech Holdings Plc (CareTech) is a children and adult care service provider. The company offers solution for adults and solution for children and young people. its adult care services includes learning disability, mental health, acquired brain injury, eating disorders, sensory impairments …
  • The Better Drinks Co Limited:企業の戦略・SWOT・財務情報
    The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report Summary The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Verseon Corp (VSN):企業の財務・戦略的SWOT分析
    Summary Verseon Corp (Verseon) is a pharmaceutical company that develops novel therapeutics. The company develops drug programs in the therapeutic areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. Its anticoagulation program develops oral anticoagulants for cardi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆